Correspondence: Oncogenic MYC persistently upregulates the molecular clock component REV-ERBα
Brian J. Altman(University of Rochester Medical Center), Chi V. Dang(Abramson Center for Jewish Life)
Cited by 23
Related Papers
Drugging the 'undruggable' cancer targets
|Nature reviews. Cancer|2017|912
Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc
|Journal of Biological Chemistry|2000|869
c-Myc Is Glycosylated at Threonine 58, a Known Phosphorylation Site and a Mutational Hot Spot in Lymphomas
|Journal of Biological Chemistry|1995|445
Candidate exome capture identifies mutation of SDCCAG8 as the cause of a retinal-renal ciliopathy
|Nature Genetics|2010|318
Future cancer research priorities in the USA: a Lancet Oncology Commission
|The Lancet Oncology|2017|209